Direct-to-Patient RTSM Date Published: Apr 27, 2022 Brochure Traditionally, the goal of clinical supply teams has been to ensure that study supplies are available for use at a clinical trial site. Today, recent trends in trial design, such as hybrid and decentralized models, have prompted the need to deliver investigational products directly to patients at their homes. Signant’s RTSM solution enables direct-to-patient clinical supply deliveries, providing benefits to all study stakeholders: Reduce burdens on patients and sites Provide full traceability Improve workflow efficiency Learn more in our brochure. Download Now Share: LinkedInTweet Recommended Resources Lessons in Direct-To-Patient RTSM Models Download Now Whitepaper Article Maximizing Clinical Supplies Efficiency: A New Approach Randomization and Trial Supply Management (RTSM) systems address study specific needs for patient randomization and medication management, while clinical supply... Download Now Signant SmartSignals RTSM Download Now Brochure